# Ethicon, Inc. clinical trials: 66 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 66 trials with Ethicon, Inc. as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Ethicon, Inc.: 66 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/ethicon-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 66
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 66, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 30, 2024 | NCT06664788 | A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery | Ethicon, Inc. | Not applicable | Completed | Hemostasis, Hemostatic Techniques | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06664788) |
| March 29, 2022 | NCT05299606 | POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy) | Ethicon, Inc. | Not applicable | Terminated | Lung Neoplasms | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05299606) |
| May 18, 2021 | NCT04889989 | Microwave Ablation in Chinese Patients With Lung Tumors | Ethicon, Inc. | Not applicable | Terminated | Cancer of the Lung | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04889989) |
| April 2, 2021 | NCT04829994 | Post-Market Clinical Follow-Up onTVT EXACT® Continence System | Ethicon, Inc. | Observational | Active not recruiting | Stress Urinary Incontinence | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04829994) |
| April 2, 2021 | NCT04829357 | Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System | Ethicon, Inc. | Observational | Recruiting | Stress Urinary Incontinence | 195 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04829357) |
| April 2, 2021 | NCT04829175 | Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry | Ethicon, Inc. | Observational | Recruiting | Stress Urinary Incontinence, Pelvic Organ Prolapse | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04829175) |
| April 2, 2021 | NCT04829058 | GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study | Ethicon, Inc. | Observational | Terminated | Pelvic Organ Prolapse | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04829058) |
| September 27, 2019 | NCT04107766 | NOLA (NeuWave Observational Liver Ablation) Registry | Ethicon, Inc. | Observational | Terminated | Cancer of the Liver, Liver Cancer, Neoplasms, Liver | 1,254 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04107766) |
| May 3, 2019 | NCT03937011 | Post-Market Clinical Follow-Up of STRATAFIX™ Spiral PDS™ PLUS | Ethicon, Inc. | Observational | Completed | Bariatric - Sleeve Gastrectomy Staple Line Reinforcement, Gynecology - Vaginal Cuff Closure | 161 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03937011) |
| March 29, 2019 | NCT03896061 | A Videographic Study to Evaluate the Impact of a Pulsed Firing Technique on Staple Line Interventions in Laparoscopic Sleeve Gastrectomy | Ethicon, Inc. | Observational | Completed | Hemostasis | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03896061) |
| January 3, 2019 | NCT03792737 | A Study of Two Types of Absorbable Surgical Sutures in the Suturing of Thyroid Surgery Incision | Ethicon, Inc. | Not applicable | Completed | Sutures | 501 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03792737) |
| December 21, 2018 | NCT03783871 | NeuWave Microwave Ablation HCC China Study | Ethicon, Inc. | Not applicable | Completed | Liver Tumor, Hepatocellular Carcinoma | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03783871) |
| December 3, 2018 | NCT03762200 | SURGICEL® Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding in Adult Subjects | Ethicon, Inc. | Not applicable | Completed | Hemorrhage | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03762200) |
| November 27, 2018 | NCT03753789 | Ablation Confirmation Study | Ethicon, Inc. | Not applicable | Terminated | Cancer of the Liver, Liver Cancer, Neoplasms, Liver | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03753789) |
| October 19, 2018 | NCT03713099 | NEUWAVE Flexible Probe Study #2 | Ethicon, Inc. | Not applicable | Withdrawn | Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer, Non-Small... | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03713099) |
| July 27, 2018 | NCT03603652 | NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung | Ethicon, Inc. | Not applicable | Terminated | Cancer of Lung, Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung... | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03603652) |
| July 13, 2018 | NCT03586050 | Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea | Ethicon, Inc. | Not applicable | Completed | Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer, Cancer, Hepatocellular | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03586050) |
| March 12, 2018 | NCT03462563 | Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™ | Ethicon, Inc. | Phase 3 | Terminated | Subjects Scheduled to Undergo Laparoscopic Radical Resection of Rectal Carcinoma With Preventive Ileostomy | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03462563) |
| August 21, 2017 | NCT03255174 | The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study | Ethicon, Inc. | Phase 3 | Completed | Controlling Mild to Moderate Bleeding During Surgery | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03255174) |
| February 17, 2017 | NCT03056300 | A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies | Ethicon, Inc. | Not applicable | Completed | Non-Small Cell Lung Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03056300) |
| May 29, 2015 | NCT02457546 | The EVICEL® Neurosurgery Phase III Study | Ethicon, Inc. | Phase 3 | Completed | Cerebrospinal Fluid Leak | 234 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02457546) |
| December 5, 2014 | NCT02309645 | The Paediatric EVICEL® Neuro Study | Ethicon, Inc. | Phase 3 | Terminated | CSF Leak | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02309645) |
| August 28, 2014 | NCT02227992 | The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study | Ethicon, Inc. | Phase 3 | Completed | Hemorrhage, Soft Tissue Bleeding, Hepatic Parenchyma Bleeding | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02227992) |
| August 28, 2014 | NCT02227706 | The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study | Ethicon, Inc. | Phase 3 | Completed | Hemorrhage, Soft Tissue Bleeding | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02227706) |
| March 24, 2014 | NCT02094885 | The Bioseal Vascular Study | Ethicon, Inc. | Phase 4 | Completed | Cardiovascular Bleeding, Vascular Bleeding, Hemorrhage | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02094885) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 2 | 4 |
| Phase 2/3 | 1 |
| Phase 3 | 15 |
| Phase 4 | 10 |
| Not applicable | 19 |
| Observational | 16 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 48 |
| Terminated | 14 |
| Recruiting | 2 |
| Active not recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hemorrhage | 9 |
| Urinary Incontinence, Stress | 6 |
| Pelvic Organ Prolapse | 6 |
| Lung Neoplasms | 4 |
| Leiomyoma | 3 |
| Liver Neoplasms | 3 |
| Cerebrospinal Fluid Otorrhea | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Menorrhagia | 3 |
| Carcinoma, Hepatocellular | 2 |
| Hernia | 2 |
| Neoplasms | 2 |
| Cardiovascular Diseases | 2 |
| Peripheral Vascular Diseases | 2 |
| Gastrointestinal Diseases | 1 |
| Migraine Disorders | 1 |
| Cystocele | 1 |
| Rectocele | 1 |
| Gigantomastia | 1 |
| Cerebrospinal Fluid Leak | 1 |
| Sinusitis | 1 |
| Diabetes Mellitus | 1 |
| Blepharoptosis | 1 |
| Neurologic Manifestations | 1 |
| Surgical Wound | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Aircraft service companies in the United States](https://specstream.ai/data/businesses/aircraft-service-companies/united-states)
- [Kosher restaurants in the United States](https://specstream.ai/data/businesses/kosher-restaurants/united-states)
- [B2B advertising and marketing companies in the United States](https://specstream.ai/data/businesses/b2b-advertising-and-marketing-companies/united-states)
- [Maternity centers in the United States](https://specstream.ai/data/businesses/maternity-centers/united-states)
- [Bangladeshi restaurants in the United States](https://specstream.ai/data/businesses/bangladeshi-restaurants/united-states)
- [Natural gas utilities in the United States](https://specstream.ai/data/businesses/natural-gas-utilities/united-states)
